Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Aclarion, Inc. (ACON)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 7,820,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Aclarion is a healthcare technology company. The first application of Co.'s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Co.'s commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. The main technology underlying NOCISCAN-LS is the use of Magnetic Resonance spectroscopy to identify the chemical makeup of intervertebral discs with a focus on identifying specific proprietary biomarkers.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 40,905
Total Buy Value $0 $0 $0 $20,768
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 4
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-25 2023-11-24 2023-05-26 2022-05-26

   
Records found: 17
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Thramann Jeffrey John Executive Chairman   •       –      –    2023-03-28 4 D $1,000.00 $1,000 D/D (1) 0     -
   Thramann Jeffrey John Executive Chairman   •       •      –    2023-02-16 4 B $1,000.00 $1,000 D/D 1 1 2.73     -
   Ness Brent Chief Executive Officer   •       •      –    2022-12-29 4 B $0.51 $8,807 D/D 16,211 19,500 2.81     -
   Lorbiecki John Paul Chief Financial Officer   •       –      –    2022-12-29 4 B $0.43 $10,000 D/D 22,404 22,404 2.74     -
   Ness Brent Chief Executive Officer   •       •      –    2022-12-28 4 B $0.42 $961 D/D 2,289 3,289 2.73     -
   Neal David K Director   –       •      –    2022-12-02 4/A A $0.00 $0 D/D 152,128 186,528     -
   Dirks Michael W Former 10% Owner   –       –      –    2022-12-02 4 D $0.00 $0 D/D (1,091,894) 0     -
   Neal David K Director   –       •      –    2022-12-02 4 D $0.00 $0 D/D (152,128) 186,528     -
   Bond Ryan Chief Strategy Officer   •       –      –    2022-04-22 4 B $2.80 $56,000 D/D 20,000 20,000 2.74     -
   Nuvasive Inc 10% Owner   –       –       •   2022-04-21 3/A IO $0.00 $0 D/D 0 1,126,495     -
   Dirks Michael W 10% Owner   –       –       •   2022-04-21 3/A IO $0.00 $0 D/D 0 1,091,894     -
   Wesemann William Director   –       •      –    2022-04-21 3/A IO $0.00 $0 D/D 0 41,736     -
   Neal David K Director   –       •      –    2022-04-21 4 B $4.35 $149,640 D/D 34,400 34,400 2.39     -
   Wesemann William Director   –       •      –    2022-04-21 4 B $4.35 $47,850 D/D 11,000 52,736 2.39     -
   Ness Brent Chief Executive Officer   •       •      –    2022-04-21 4 B $4.35 $4,350 D/D 1,000 1,000 2.73     -
   Nuvasive Inc 10% Owner   –       –       •   2022-04-21 3 IO $0.00 $0 D/D 0 1,114,247     -
   Dirks Michael W 10% Owner   –       –       •   2022-04-21 3 IO $0.00 $0 D/D 0 1,101,280     -

  17 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed